Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M21,981Revenue (TTM) $M9,749Net Margin (%)8.3Altman Z-Score2.1
Enterprise Value $M28,257EPS (TTM) $1.6Operating Margin %14.4Piotroski F-Score5
P/E(ttm)27.7Beneish M-Score-2.5Pre-tax Margin (%)9.0Higher ROA y-yN
Price/Book2.010-y EBITDA Growth Rate %13.1Quick Ratio1.1Cash flow > EarningsY
Price/Sales2.35-y EBITDA Growth Rate %7.5Current Ratio1.7Lower Leverage y-yY
Price/Free Cash Flow15.1y-y EBITDA Growth Rate %2.7ROA % (ttm)3.6Higher Current Ratio y-yY
Dividend Yield %--PEG3.7ROE % (ttm)8.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M508ROIC % (ttm)7.7Gross Margin Increase y-yN

Gurus Latest Trades with MYL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MYLDavid Tepper 2016-03-31 Sold Out -0.92%$41.42 - $54.09
($48.28)
$ 43.24-10%Sold Out0
MYLJoel Greenblatt 2016-03-31 Add0.44%$41.42 - $54.09
($48.28)
$ 43.24-10%Add 9178.19%837,728
MYLVanguard Health Care Fund 2016-03-31 Add0.25%$41.42 - $54.09
($48.28)
$ 43.24-10%Add 10.00%26,679,385
MYLJohn Paulson 2016-03-31 Add0.19%$41.42 - $54.09
($48.28)
$ 43.24-10%Add 2.38%23,335,861
MYLJohn Keeley 2016-03-31 Sold Out -0.09%$41.42 - $54.09
($48.28)
$ 43.24-10%Sold Out0
MYLMario Gabelli 2016-03-31 Reduce$41.42 - $54.09
($48.28)
$ 43.24-10%Reduce -35.73%17,000
MYLDavid Einhorn 2015-12-31 Buy 2.86%$39.16 - $55.28
($48.35)
$ 43.24-11%New holding2,890,000
MYLDavid Tepper 2015-12-31 Add0.41%$39.16 - $55.28
($48.35)
$ 43.24-11%Add 81.62%853,749
MYLJohn Paulson 2015-12-31 Add0.29%$39.16 - $55.28
($48.35)
$ 43.24-11%Add 4.02%22,794,061
MYLVanguard Health Care Fund 2015-12-31 Add0.11%$39.16 - $55.28
($48.35)
$ 43.24-11%Add 4.26%24,253,075
MYLMario Gabelli 2015-12-31 Reduce-0.01%$39.16 - $55.28
($48.35)
$ 43.24-11%Reduce -60.67%26,450
MYLJoel Greenblatt 2015-12-31 Buy 0.01%$39.16 - $55.28
($48.35)
$ 43.24-11%New holding9,029
MYLJohn Keeley 2015-12-31 Reduce$39.16 - $55.28
($48.35)
$ 43.24-11%Reduce -8.09%51,580
MYLDavid Tepper 2015-09-30 Reduce-0.87%$39.8 - $71.49
($55.75)
$ 43.24-22%Reduce -52.50%470,071
MYLVanguard Health Care Fund 2015-09-30 Add0.64%$39.8 - $71.49
($55.75)
$ 43.24-22%Add 46.38%23,262,875
MYLJohn Keeley 2015-09-30 Add0.02%$39.8 - $71.49
($55.75)
$ 43.24-22%Add 51.47%56,120
MYLMario Gabelli 2015-09-30 Add0.01%$39.8 - $71.49
($55.75)
$ 43.24-22%Add 102.26%67,250
MYLJohn Paulson 2015-06-30 Add2.24%$57.94 - $76.06
($70.49)
$ 43.24-39%Add 46.59%21,913,061
MYLDavid Tepper 2015-06-30 Buy 1.66%$57.94 - $76.06
($70.49)
$ 43.24-39%New holding989,528
MYLFirst Eagle Investment 2015-06-30 Sold Out -0.08%$57.94 - $76.06
($70.29)
$ 43.24-38%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MYL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MYL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MAROON JOSEPH C MDDirector 2016-06-03Buy1,670$44.95-3.8view
MAROON JOSEPH C MDDirector 2016-05-25Buy2,370$42.471.81view
Cindrich Robert JDirector 2016-05-25Buy1,190$42.471.81view
HIGGINS MELINA EDirector 2016-05-12Buy19,900$38.6811.79view
HIGGINS MELINA EDirector 2016-05-06Buy100$38.6911.76view
HIGGINS MELINA EDirector 2016-04-28Buy35,000$42.920.75view
COURY ROBERT JExecutive Chairman 2016-04-05Sell217,755$45.96-5.92view
MAROON JOSEPH C MDDirector 2016-03-31Buy4,337$46.36-6.73view
PARRISH MARK WDirector 2016-03-17Buy1,705$44-1.73view
CAMERON WENDYDirector 2016-03-08Buy2,190$45.69-5.36view

Press Releases about MYL :

Quarterly/Annual Reports about MYL:

News about MYL:

Articles On GuruFocus.com
Growing Generic Drug Market a Good Opportuity for 2 India Firms May 30 2016 
Samuel Isaly Trades in Health Care Stocks in 1st Quarter Apr 27 2016 
John Keeley Comments on Mylan Labs Apr 26 2016 
Ackman to Testify About Valeant Before Senate Apr 26 2016 
Mawer's Investment Newsletter 1st Quarter Apr 15 2016 
Insiders Keep on Selling Facebook and Ford Apr 08 2016 
Buy Perrigo After a Big Selloff? Yes Apr 04 2016 
David Einhorn's Top 5 New Q4 Buys Feb 16 2016 
David Einhorn Rebounds – Somewhat Feb 09 2016 
Keeley Funds Comments on Mylan N.V. Feb 03 2016 

More From Other Websites
EU mergers and takeovers (June 30) Jun 30 2016
What New Medicines Were Recommended during the CHMP’s June Meeting? Jun 28 2016
Inside the CHMP’s June Meeting and Outcome Jun 28 2016
Mylan’s Key Developments and Big Plans: What You Should Know Jun 28 2016
Mylan CEO Bresch on Brexit Exposure, Regulation Jun 28 2016
Mylan CEO Bresch on Brexit Exposure, Regulation Jun 28 2016
Mylan’s Profits: Can You Expect Changes? Jun 28 2016
Mylan Launches Generic Version of Glaxo's Avodart in U.S. Jun 27 2016
Why Mylan’s Specialty Segment Reported Strong Q1 Growth Jun 27 2016
Mylan NV breached its 50 day moving average in a Bearish Manner : MYL-US : June 27, 2016 Jun 27 2016
Mylan’s Generics Segment: 1Q16 Must-Knows Jun 27 2016
MYLAN N.V. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 24 2016
Mylan Unveils Generic Avodart Capsules Jun 24 2016
What’s the Story behind Mylan’s Revenue Growth? Jun 24 2016
Why Is Mylan’s Valuation so Low? Our Diagnosis Jun 24 2016
Mylan Launches Generic Avodart® Capsules Jun 24 2016
J.P. Morgan Very Positive on 3 Battered Specialty Pharmaceutical Stocks Jun 24 2016
Mylan Donates €1 Million to the Princess Máxima Center for Pediatric Oncology Jun 23 2016
Valeant Pharmaceuticals: Now You Downgrade It? Jun 23 2016
Mylan Says Indian Drug Industry Needs More Transparency From FDA Jun 23 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)